open access

Vol 77, No 4 (2009)
EDUCATION
Published online: 2009-06-26
Submitted: 2013-02-22
Get Citation

Severe and terminal chronic obstructive pulmonary disease

Ewa Jassem, Dorota Górecka
Pneumonol Alergol Pol 2009;77(4):411-416.

open access

Vol 77, No 4 (2009)
EDUCATION
Published online: 2009-06-26
Submitted: 2013-02-22

Abstract

Not available

Abstract

Not available
Get Citation
About this article
Title

Severe and terminal chronic obstructive pulmonary disease

Journal

Advances in Respiratory Medicine

Issue

Vol 77, No 4 (2009)

Pages

411-416

Published online

2009-06-26

Bibliographic record

Pneumonol Alergol Pol 2009;77(4):411-416.

Authors

Ewa Jassem
Dorota Górecka

References (51)
  1. www.goldcopd.org.
  2. Pływaczewski R, Maciejewski J, Bednarek M, et al. Prevalence, severity and underdiagnosis of COPD in the primary care setting. Thorax. 2008; 63(5): 402–407.
  3. Hajiro T, Nishimura K, Tsukino M, et al. A comparison of the level of dyspnea vs disease severity in indicating the health-related quality of life of patients with COPD. Chest. 1999; 116(6): 1632–1637.
  4. Budweiser S, Hitzl AP, Jörres RA, et al. Health-related quality of life and long-term prognosis in chronic hypercapnic respiratory failure: a prospective survival analysis. Respir Res. 2007; 8: 1–9.
  5. Rizkallah J, Man SF, Sin DD. Prevalence of pulmonary embolism in acute exacerbations of COPD: a systematic review and metaanalysis. Chest. 2009; 135(3): 786–793.
  6. Maters GA, de Voogd JN, Sanderman R, et al. Depressive symptoms as predictors of mortality in patients with COPD. Chest. 2009; 135(3): 619–625.
  7. Budweiser S, Jörres RA, Riedl T, et al. Predictors of survival in COPD patients with chronic hypercapnic respiratory failure receiving noninvasive home ventilation. Chest. 2007; 131(6): 1650–1658.
  8. Ong KC, Lu SJ, Soh CSC. Does the multidimensional grading system (BODE) correspond to differences in health status of patients with COPD? Int J Chron Obstruct Pulmon Dis. 2006; 1(1): 91–96.
  9. Celli BR, Cote CG, Marin JM, et al. The body-mass index, airflow obstruction, dyspnea, and exercise capacity index in chronic obstructive pulmonary disease. N Engl J Med. 2004; 350(10): 1005–1012.
  10. Cote CG, Dordelly LJ, Celli BR. Impact of COPD exacerbations on patient-centered outcomes. Chest. 2007; 131(3): 696–704.
  11. Cote CG, Pinto-Plata VM, Marin JM, et al. The modified BODE index validation with mortality in COPD. ERJ. 2008; 102: 27–35.
  12. Tantucci C, Donati P, Nicosia F, et al. Inspiratory capacity predicts mortality in patients with chronic obstructive pulmonary disease. Respir Med. 2008; 102(4): 613–619.
  13. Casanova C, Cote C, de Torres JP, et al. Inspiratory-to-total lung capacity ratio predicts mortality in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2005; 171(6): 591–597.
  14. Burgel PR, Nesme-Meyer P, Chanez P, et al. Initiatives Bronchopneumopathie Chronique Obstructive Scientific Committee. Cough and sputum production are associated with frequent exacerbations and hospitalizations in COPD subjects. Chest. 2009; 135(4): 975–982.
  15. Man SFP, Connett JE, Anthonisen NR, et al. C-reactive protein and mortality in mild to moderate chronic obstructive pulmonary disease. Thorax. 2006; 61(10): 849–856.
  16. Man SFP, Xing L, Connett JE, et al. Circulating fibronectin to C-reactive protein ratio and mortality: a biomarker in COPD? Eur Respir J. 2008; 32(6): 1451–1457.
  17. Claessens MT, Lynn J, Zhong Z, et al. Dying with lung cancer or chronic obstructive pulmonary disease: insights from SUPPORT. Study to Understand Prognoses and Preferences for Outcomes and Risks of Treatments. J Am Geriatr Soc. 2000; 48(5 Suppl): S146–S153.
  18. Vestbo J, Prescott E, Almdal T, et al. Body mass, fat-free body mass, and prognosis in patients with chronic obstructive pulmonary disease from a random population sample: findings from the Copenhagen City Heart Study. Am J Respir Crit Care Med. 2006; 173(1): 79–83.
  19. Cooper CB, Waterhouse J, Howard P. Twelve year clinical study of patients with hypoxic cor pulmonale given long term domiciliary oxygen therapy. Thorax. 1987; 42(2): 105–110.
  20. Nizet TAC, van den Elshout FJJ, Heijdra YF, et al. Survival of chronic hypercapnic COPD patients is predicted by smoking habits, comorbidity, and hypoxemia. Chest. 2005; 127(6): 1904–1910.
  21. Murray SA, Kendall M, Boyd K, et al. Illness trajectories and palliative care. BMJ. 2005; 330(7498): 1007–1011.
  22. Curtis JR. Palliative and end-of-life care for patients with severe COPD. Eur Respir J. 2008; 32(3): 796–803.
  23. Coventry PA, Grande GE, Richards DA, et al. Prediction of appropriate timing of palliative care for older adults with non-malignant life-threatening disease: a systematic review. Age Ageing. 2005; 34(3): 218–227.
  24. Le Jemtel TH, Padeletti M, Jelic S. Diagnostic and therapeutic challenges in patients with coexistent chronic obstructive pulmonary disease and chronic heart failure. J Am Coll Cardiol. 2007; 49(2): 171–180.
  25. Di Fazio I, Franzoni S, Frisoni GB, et al. Predictive role of single diseases and their combination on recovery of balance and gait in disabled elderly patients. J Am Med Dir Assoc. 2006; 7(4): 208–211.
  26. Anthonisen NR, Skeans MA, Wise RA, et al. Lung Health Study Research Group. The effects of a smoking cessation intervention on 14.5-year mortality: a randomized clinical trial. Ann Intern Med. 2005; 142(4): 233–239.
  27. Tashkin DP, Celli B, Senn S, et al. A 4-year trial of tiotropium in chronic obstructive pulmonary disease. NEJM. 2008; 359: 1616–1618.
  28. Calverley P, Pauwels R, Vestbo J, et al. TRial of Inhaled STeroids ANd long-acting beta2 agonists study group. Combined salmeterol and fluticasone in the treatment of chronic obstructive pulmonary disease: a randomised controlled trial. Lancet. 2003; 361(9356): 449–456.
  29. Sobieraj DM, White CM, Coleman CI. Benefits and risks of adjunctive inhaled corticosteroids in chronic obstructive pulmonary disease: a meta-analysis. Clin Ther. 2008; 30(8): 1416–1425.
  30. Hess DR. The evidence for noninvasive positive-pressure ventilation in the care of patients in acute respiratory failure: a systematic review of the literature. Respir Care. 2004; 49(7): 810–829.
  31. Borghi-Silva A, Reis MS, Mendes RG, et al. Noninvasive ventilation acutely modifies heart rate variability in chronic obstructive pulmonary disease patients. Respir Med. 2008; 102(8): 1117–1123.
  32. Dreher M, Doncheva E, Schwoerer A, et al. Preserving oxygenation during walking in severe chronic obstructive pulmonary disease: noninvasive ventilation versus oxygen therapy. Respiration. 2009; 78(2): 154–160.
  33. Keilty SE, Ponte J, Fleming TA, et al. Effect of inspiratory pressure support on exercise tolerance and breathlessness in patients with severe stable chronic obstructive pulmonary disease. Thorax. 1994; 49(10): 990–994.
  34. Cuomo A, Delmastro M, Ceriana P, et al. Noninvasive mechanical ventilation as a palliative treatment of acute respiratory failure in patients with end-stage solid cancer. Palliat Med. 2004; 18(7): 602–610.
  35. Lanken PN, Terry PB, Delisser HM, et al. ATS End-of-Life Care Task Force. An official American Thoracic Society clinical policy statement: palliative care for patients with respiratory diseases and critical illnesses. Am J Respir Crit Care Med. 2008; 177(8): 912–927.
  36. Lacasse Y, Martin S, Lasserson TJ, et al. Meta-analysis of respiratory rehabilitation in chronic obstructive pulmonary disease. A Cochrane systematic review. Eura Medicophys. 2007; 43(4): 475–485.
  37. Foglio K, Bianchi L, Bruletti G, et al. Seven-year time course of lung function, symptoms, health-related quality of life, and exercise tolerance in COPD patients undergoing pulmonary rehabilitation programs. Respir Med. 2007; 101(9): 1961–1970.
  38. Carone M, Patessio A, Ambrosino N, et al. Efficacy of pulmonary rehabilitation in chronic respiratory failure (CRF) due to chronic obstructive pulmonary disease (COPD): The Maugeri Study. Respir Med. 2007; 101(12): 2447–2453.
  39. Martin UJ, Hincapie L, Nimchuk M, et al. Impact of whole-body rehabilitation in patients receiving chronic mechanical ventilation. Crit Care Med. 2005; 33(10): 2259–2265.
  40. Navigante AH, Cerchietti LCA, Castro MA, et al. Midazolam as adjunct therapy to morphine in the alleviation of severe dyspnea perception in patients with advanced cancer. J Pain Symptom Manage. 2006; 31(1): 38–47.
  41. Gore JM, Brophy CJ, Greenstone MA. How well do we care for patients with end stage chronic obstructive pulmonary disease (COPD)? A comparison of palliative care and quality of life in COPD and lung cancer. Thorax. 2000; 55(12): 1000–1006.
  42. Clemens KE, Klaschik E. Symptomatic therapy of dyspnea with strong opioids and its effect on ventilation in palliative care patients. J Pain Symptom Manage. 2007; 33(4): 473–481.
  43. Croft M. Palliative care in end-stage COPD. Br J Gen Pract. 2005; 55(512): 234.
  44. Rocker GM, Dodek PM, Heyland DK, et al. Canadian Researchers at the End of Life Network. Toward optimal end-of-life care for patients with advanced chronic obstructive pulmonary disease: insights from a multicentre study. Can Respir J. 2008; 15(5): 249–254.
  45. Habraken JM, Pols J, Bindels PJE, et al. The silence of patients with end-stage COPD: a qualitative study. Br J Gen Pract. 2008; 58(557): 844–849.
  46. Steinhauser KE, Clipp EC, McNeilly M, et al. In search of a good death: observations of patients, families, and providers. Ann Intern Med. 2000; 132(10): 825–832.
  47. Knauft E, Nielsen EL, Engelberg RA, et al. Barriers and facilitators to end-of-life care communication for patients with COPD. Chest. 2005; 127(6): 2188–2196.
  48. Kirk P, Kirk I, Kristjanson LJ. What do patients receiving palliative care for cancer and their families want to be told? A Canadian and Australian qualitative study. BMJ. 2004; 328(7452): 1343.
  49. Selecky PA, Eliasson CA, Hall RI, et al. American College of Chest Physicians. Palliative and end-of-life care for patients with cardiopulmonary diseases: American College of Chest Physicians position statement. Chest. 2005; 128(5): 3599–3610.
  50. Casas A, Troosters T, Garcia-Aymerich J, et al. members of the CHRONIC Project. Integrated care prevents hospitalisations for exacerbations in COPD patients. Eur Respir J. 2006; 28(1): 123–130.
  51. Spence A, Hasson F, Waldron M, et al. Active carers: living with chronic obstructive pulmonary disease. Int J Palliat Nurs. 2008; 14(8): 368–372.

Important: This website uses cookies. More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

Czasopismo Pneumonologia i Alergologia Polska dostęne jest również w Ikamed - księgarnia medyczna

Wydawcą serwisu jest "Via Medica sp. z o.o." sp.k., ul. Świętokrzyska 73, 80–180 Gdańsk

tel.:+48 58 320 94 94, faks:+48 58 320 94 60, e-mail: viamedica@viamedica.pl